Tuesday, 20 Mar 2018

You are here

The RheumNow Week in Review - 23 February 2018

Dr Jack Cush reviews highlights from the past week on RheumNow.com. This week’s video is in two parts; for part Ii, go to https://buff.ly/2BM9MjL

  1. Duke Federico of Montefeltro (1422-1482) shown to have #gout based on letters and examination of skeletal remains. Gout was alive and active during the Italian Renaissance. https://t.co/yNnYWZlU5G
  2. Gout management by UK Rheums conform to guidelines, yet ~45% reach target SUA<6.0.  Study of 4343 Gout pts; 82% M; 13% crystal-proven. 29% stopped diuretic, 76% on ULT; prophylaxis was co-prescribed for 94%. https://buff.ly/2F0yLlA
  3. FDA grants "breakthrough" status to Pfizers Xeljanz (tofacitinib) for phase III trials in atopic dermatitis https://t.co/hzdMTjxmg1
  4. Dr. Hyman Zimmerman is famous for drug-induced hepatocellular injury plus jaundice conferring a 10% mortality rate. "Hy's Law" is used by the FDA to judge serious hepatotoxicity and risk of death; Requires evidence of jaundice and ALT/AST >3x ULN https://t.co/qu65fdGscf
  5. Australian study shows ACL injuries in children  have increased 148% in 10 yrs (2.74 per 100,000 2005 to 6.79 per 100,000 in 2015). US pediatricians have also reported increases in ACL tears in children/teens. https://t.co/Z5m2vQvlEk
  6. PANTS study: Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP
  7. 3 decade study from Mayo clinic shows the incidence of symptomatic and asymptomatic renal stones increased 14-29% per 5 years in men and women https://t.co/yMmsQkxxHx
  8. Dentists are ill at ease providing dental surgery to patients on bisphosphonates. 63% active ask about BP Rx, 85% reluctant to do dental surgery if on BP Rx. https://t.co/pkmuvKGMT3
  9. Oral Anticoagulation Effective Following Hip and Knee Replacement Surgery  
  10. Are ANA Tests Unreliable 
  11. Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk  
  12. HERO Trial - Hydroxychloroquine Fails in Hand Osteoarthritis 
  13. Apremilast Continues to Look Good in Behcet's Disease 


The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

MMWR: Arthritis Prevalence Increases and Varies Widely

MMWR reports that In 2015, the number of adults with arthritis continued to increase; with marked geographic variability in arthritis estimates with gaps in arthritis management.

The CDC estimates that physician-diagnosed arthritis affects 54 million of adults in the United States with an annual cost of approximately $300 billion annually.

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

The RheumNow Week in Review - 9 March 2018

Dr. Jack Cush reviews highlights, news and recent research published this past week on RheumNow.com. This week's report includes news on new regulatory changes, new indication for tofacitinib, the rise and deficits of opioids and the benefits of fish and bariatric surgery.

ACR Responds to Association Health Plans Proposed Rule

In comments submitted today to the US Department of Labor in response to its Association Health Plans (AHP) proposed rule, the American College of Rheumatology urged Administration officials to protect essential health benefits and other consumer protections that make it possible for individuals living with rheumatic diseases to access comprehensive and affordable healthcare.

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.